Assessment of coenzyme Q10 absorption using an in vitro digestion-Caco-2 cell model

International Journal of Pharmaceutics

Volumn 333, Issue 1-2, 2007, Pages 112-117

  Bhagavan, Hemmi N ^a   Chopra, Raj K ^a   Craft, Neal E ^b   Chitchumroonchokchai, Chureeporn ^c   Failla, Mark L ^c  

^a Tishcon Corporation   (United States)

^b Craft Technologies Inc   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Bioavailability; Caco 2 cells; Coenzyme Q10; In vitro models; Intestinal absorption; Ubiquinone

Indexed keywords

CHEW Q; HYDRO Q SORB; LIQUID Q; Q GEL; UBIDECARENONE; UBIQUINONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG STRUCTURE; DRUG UPTAKE; GASTROINTESTINAL TRACT; IN VITRO STUDY; INTESTINE ABSORPTION; MICELLE; NONHUMAN; PRIORITY JOURNAL;

BIOLOGICAL AVAILABILITY; BIOTRANSFORMATION; CACO-2 CELLS; CHEMISTRY, PHARMACEUTICAL; DIGESTION; DRUG STABILITY; EXCIPIENTS; FEASIBILITY STUDIES; GAMMA-CYCLODEXTRINS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MICELLES; POWDERS; SOLUBILITY; TABLETS; TIME FACTORS; UBIQUINONE; VITAMINS;

EID: 33847164018     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.10.007     Document Type: Article

References (27)

1. Aberg F., Appelkvist E.L., Dallner G., and Ernster L. Distribution and redox state of ubiquinones in rat and human tissues. Arch. Biochem. Biophys. 295 (1992) 230-234
2. Beal M.F. Coenzyme Q10 as a possible treatment for neurodegenerative diseases. Free Radic. Res. 36 (2002) 455-460
3. Chitchumroonchokchai J., and Failla M.L. Hydrolysis of zeaxanthin esters by carboxyl ester lipase during digestion facilitates micellarization and uptake of zeaxanthin by Caco-2 human intestinal cells. J. Nutr. 136 (2006) 588-594
4. Chitchumroonchokchai C., Schwartz S.J., and Failla M.L. Assessment of lutein bioavailability from meals and a supplement using simulated digestion and Caco-2 human intestinal cells. J. Nutr. 134 (2004) 2280-2286
5. Chopra R.K., Goldman R., Sinatra S.T., and Bhagavan H.N. Relative bioavailability of coenzyme Q10 formulations in human subjects. Int. J. Vit. Nutr. Res. 68 (1998) 109-113
6. Craft N.E., Tucker R.T., Chitchumroonchokchai C., Failla M., and Bhagavan H.N. Assessment of coenzyme Q10 bioavailability using a coupled in vitro digestion/Caco-2 human intestinal cell model. FASEB J. 19 (2005) A449
7. Crane F.L. Biochemical functions of coenzyme Q10. J. Am. Coll. Nutr. 20 (2001) 591-598
8. Davis M.E., and Brewster M.E. Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. Drug Discov. 3 (2004) 1023-1035
9. Delie F., and Rubas W. A human colonic cell line haring similarities with enterocytes as a model to examine oral absorption: advances and limitations of the Caco-2 model. Crit. Rev. Ther. Drug Carrier Syst. 14 (1997) 221-286
10. Ernster L., and Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1271 (1995) 195-204
11. Etcheverry P., Wallingford J.C., Miller D.D., and Glahn R.P. Calcium, zinc, and iron bioavailabilities from a commercial human milk fortifier: a comparison study. J. Dairy Sci. 87 (2004) 3629-3637
12. Failla, M.L., Chitchumroonchokchai, C., 2005. In vitro models as tools for screening the relative bioavailabilities of provitamin A carotenoids in foods. HarvestPlus Technical Monograph Series #3, 32 pp. http://www.harvestplus.org/pubs.html.
13. Garrett D.A., Failla M.L., and Sarama R.J. Development of an in vitro digestion method to assess carotenoid bioavailability from meals. J. Agric. Food Chem. 47 (1999) 4301-4309
14. Garrett D.A., Failla M.L., Sarama R.J., and Craft N. Accumulation and retention of micellar beta-carotene and lutein by Caco-2 human intestinal cells. J. Nutr. Biochem. 10 (1999) 573-581
15. Gibaldi M., and Weintraub H. Quantitative correlation of absorption and in vitro dissolution kinetics of aspirin from several dosage forms. J. Pharm. Sci. 59 (1970) 725-726
16. 3H)-coenzyme Q10 in rats. Chem. Pharm. Bull. 250 (1972) 2585-2592
17. Kayden H.J., and Traber M.G. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J. Lipid Res. 34 (1993) 343-358
18. Langsjoen P.H., and Langsjoen A.M. Overview of the use of coenzyme Q10 in cardiovascular disease. Biofactors 9 (1999) 273-284
19. Lau Y.Y., Chen Y.H., Liu T.T., Li C., Cui X., White R.E., and Cheng K.C. Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability. Drug Metab. Dispos. 32 (2004) 937-942
20. Miles M.V., Horn P., Miles L., Tang P., Steele P., and DeGrauw T. Bioequivalence of coenzyme Q10 from over-the-counter supplements. Nutr. Res. 22 (2002) 919-929
21. Mohr D., Umeda Y., Redgrave T.G., and Stocker R. Antioxidant defenses in rat intestine and mesenteric lymph. Redox Rep. 4 (1999) 79-87
22. Overvad K., Diamant B., Holm L., Holmer G., Mortensen S.A., and Stender S. Coenzyme Q10 in health and disease. Eur. J. Clin. Nutr. 53 (1999) 764-770
23. Rousseau G., and Varin F. Determination of ubiquinone-9 and 10 levels in rat tissues and blood by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. Sci. 36 (1998) 247-252
24. Shimpi S., Chauhan B., and Shimpi B. Cyclodextrins: application in different routes of drug administration. Acta Pharm. 55 (2005) 139-156
25. Tang P.H., Miles M.V., DeGrauw A., Hershey A., and Pesce A. HPLC analysis of reduced and oxidized coenzyme Q (10) in human plasma. Clin. Chem. 47 (2001) 256-265
26. Zaghloul A.A., Gurley B., Khan M., Bhagavan H., Chopra R., and Reddy I. Bioavailability assessment of oral coenzyme Q10 formulations in dogs. Drug Dev. Ind. Pharm. 28 (2002) 1195-1200
27. Zhang Y., Aberg F., Appelkvist E.-L., Dallner G., and Ernster L. Uptake of dietary coenzyme Q supplement is limited in rats. J. Nutr. 125 (1995) 446-453